High Purity Pharmaceutical Grade 877399-52-5 Crizotinib for Anti-cancer Treatment

Description:

Puritas:≧99%, Alba ad off-album crystallinum pulveris

Qualitas Latin:In-Domus aut quod erat faciendum

Capacitas:50Kgs/mense

Fasciae vita:3 Years

Applicatio:Cancri iaculis genus medicamentum;provectus non parva cellula pulmonis cancer

Quadrigis Commodum:Periti export venditionesque quadrigis ad professionem exercere in officinas

Mitte ad nos inscriptio Download as PDF

Product Detail

FAQ

Product Tags

Productumnomen	Crizotinib
Synonyma	PF-02341066;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridinum-2-amine;PF 2341066
CAS Non.	877399-52-5
Aspectus	Alba ut off-alba crystallina pulveris
Formulae hypotheticae	C₂₁H₂₂Cl₂FN₅O
M. Pondus	450.34
Consuetudinem	Pharmaceutical Grade vel Research proposito
stipare	Quod per petitio tua
Repono	Serva in stricta, levis vasis repugnans in loco frigido

CrizotinibCas: 877399-52-5
Items	Specifications	Proventus
Aspectus	Alba ut off-alba crystallina pulveris	Album pulveris crystallini
Lepidium sativum	H-NMR, MS	Obsequitur
RELICTUM Solvents	isopropanol≤0.5% EtOAc≤0.5% THF≤0.072% n-Heptane≤0.5% Toluene≤0.5%	0.3% ND ND ND ND ND
Metalla gravis	≤10ppm	Obsequitur
Aqua contenta	£0.5%	0.3%
Reliqua ignitio	£0.5%	0.05%
Enantiomer	£0.1%	LOQ
Related immunditiam ab HPLC	Uno impuritate≤0.1% Totalis immunditiae ≤1.0%	0.05% 0.12%
Munditia (HPLC)	³99.0%	99.88%

Company Information

√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus;
√ Quality is always our top consideration, Strict QC system;
√ 11 annos periti quadrigis venditio educendi;
√ Independentes R&D lab;
√ Duae officinae GMP terminus signati longi sunt;
√ Divites copiarum otiosorum officinarum copia pro project nativus;
√ High Efficiency working team with consistent path.
imgsaf